Literature DB >> 15715522

Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates.

Alan R Rendina1, Dong Cheng.   

Abstract

C75, a synthetic inhibitor of FAS (fatty acid synthase), has both anti-tumour and anti-obesity properties. In this study we provide a detailed kinetic characterization of the mechanism of in vitro inhibition of rat liver FAS. At room temperature, C75 is a competitive irreversible inhibitor of the overall reaction with regard to all three substrates, i.e. acetyl-CoA, malonyl-CoA and NADPH, exhibiting pseudo-first-order kinetics of the complexing type, i.e. a weak non-covalent enzyme-inhibitor complex is formed before irreversible enzyme modification. C75 is a relatively inefficient inactivator of FAS, with a maximal rate of inactivation of 1 min(-1) and an extrapolated K(I) (dissociation constant for the initial complex) of approx. 16 mM. The apparent second-order rate constants calculated from these values are 0.06 mM(-1).min(-1) at room temperature and 0.21 mM(-1).min(-1) at 37 degrees C. We also provide experimental evidence that C75 inactivates the beta-ketoacyl synthase (3-oxoacyl synthase) partial activity of FAS. Unexpectedly, C75 also inactivates the enoyl reductase and thioesterase partial activities of FAS with about the same rates as for inactivation of the beta-ketoacyl synthase. In contrast with the overall reaction, the beta-ketoacyl synthase activity and the enoyl reductase activity, substrates do not protect the thioesterase activity of rat liver FAS from inactivation by C75. These results differentiate inactivation by C75 from that by cerulenin, which only inactivates the beta-ketoacyl synthase activity of FAS, by forming an adduct with an active-site cysteine. Interference by dithiothreitol and protection by the substrates, acetyl-CoA, malonyl-CoA and NADPH, further distinguish the mechanism of C75-mediated inactivation from that of cerulenin. The most likely explanation for the multiple effects observed with C75 on rat liver FAS and its partial reactions is that there are multiple sites of interaction between C75 and FAS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715522      PMCID: PMC1183470          DOI: 10.1042/BJ20041963

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

Review 1.  Structural and functional organization of the animal fatty acid synthase.

Authors:  Stuart Smith; Andrzej Witkowski; Anil K Joshi
Journal:  Prog Lipid Res       Date:  2003-07       Impact factor: 16.195

2.  Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors.

Authors:  T M Loftus; D E Jaworsky; G L Frehywot; C A Townsend; G V Ronnett; M D Lane; F P Kuhajda
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

3.  Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents.

Authors:  Kenneth W Rohrbach; Songping Han; Jinping Gan; Eva J O'Tanyi; Hongwei Zhang; Cecilia L Chi; Rebecca Taub; Brian L Largent; Dong Cheng
Journal:  Eur J Pharmacol       Date:  2005-03-21       Impact factor: 4.432

4.  Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.

Authors:  E S Pizer; J Thupari; W F Han; M L Pinn; F J Chrest; G L Frehywot; C A Townsend; F P Kuhajda
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

5.  Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice.

Authors:  Monica V Kumar; Teruhiko Shimokawa; Tim R Nagy; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

6.  Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase.

Authors:  X Wang; W Tian
Journal:  Biochem Biophys Res Commun       Date:  2001-11-16       Impact factor: 3.575

7.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.

Authors:  Yasuhiko Minokoshi; Thierry Alquier; Noboru Furukawa; Yong-Bum Kim; Anna Lee; Bingzhong Xue; James Mu; Fabienne Foufelle; Pascal Ferré; Morris J Birnbaum; Bettina J Stuck; Barbara B Kahn
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

8.  Hypothalamic malonyl-CoA as a mediator of feeding behavior.

Authors:  Zhiyuan Hu; Seung Hun Cha; Shigeru Chohnan; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-07       Impact factor: 11.205

9.  C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism.

Authors:  Leslie E Landree; Andrea L Hanlon; David W Strong; Gavin Rumbaugh; Ian M Miller; Jagan N Thupari; Erin C Connolly; Richard L Huganir; Christine Richardson; Lee A Witters; Francis P Kuhajda; Gabriele V Ronnett
Journal:  J Biol Chem       Date:  2003-11-13       Impact factor: 5.157

10.  C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.

Authors:  Jagan N Thupari; Leslie E Landree; Gabriele V Ronnett; Francis P Kuhajda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

View more
  22 in total

Review 1.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Metabolic alterations and targeted therapies in prostate cancer.

Authors:  Richard Flavin; Giorgia Zadra; Massimo Loda
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

Review 3.  Fatty acid synthase as a potential therapeutic target in cancer.

Authors:  Richard Flavin; Stephane Peluso; Paul L Nguyen; Massimo Loda
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

4.  In silico investigation of lavandulyl flavonoids for the development of potent fatty acid synthase-inhibitory prototypes.

Authors:  Joonseok Oh; Haining Liu; Hyun Bong Park; Daneel Ferreira; Gil-Saeng Jeong; Mark T Hamann; Robert J Doerksen; MinKyun Na
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-08-13       Impact factor: 3.770

5.  Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.

Authors:  Hailan Liu; Jing-Yuan Liu; Xi Wu; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2010-07-18

6.  Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes.

Authors:  Margaret Wu; Sheo B Singh; Jun Wang; Christine C Chung; Gino Salituro; Bindhu V Karanam; Sang Ho Lee; Maryann Powles; Kenneth P Ellsworth; Michael E Lassman; Corey Miller; Robert W Myers; Michael R Tota; Bei B Zhang; Cai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-09       Impact factor: 11.205

7.  Luminal fructose inhibits rat intestinal sodium-phosphate cotransporter gene expression and phosphate uptake.

Authors:  Séverine Kirchner; Anjali Muduli; Donatella Casirola; Kannitha Prum; Véronique Douard; Ronaldo P Ferraris
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

8.  The effects of C75, an inhibitor of fatty acid synthase, on sleep and metabolism in mice.

Authors:  Jacob Pellinen; Éva Szentirmai
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

9.  Natural compounds as regulators of the cancer cell metabolism.

Authors:  Claudia Cerella; Flavia Radogna; Mario Dicato; Marc Diederich
Journal:  Int J Cell Biol       Date:  2013-05-16

10.  Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism.

Authors:  Céline Douarre; Carole Sourbier; Ilaria Dalla Rosa; Benu Brata Das; Christophe E Redon; Hongliang Zhang; Len Neckers; Yves Pommier
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.